October 29, 2016

The WHO Alliance for the Global Elimination of Trachoma by the year 2020 (GET2020) has been awarded the ‘Global Partnership Award’ during the 10th General Assembly of the International Agency for the Prevention of Blindness (IAPB).

August 10, 2016

The Task Force for Global Health, ITI's umbrella organization, is often described as a partner among partners, fighting diseases that affect the world’s most disadvantaged people and shining the light on local partners, governments and communities. Yesterday, the light was firmly on the Task Force when it was awarded the Hilton Prize, the world's largest humanitarian prize for 30 years of work in the humanitarian sector.

July 25, 2016

Ethiopia's 16th Trachoma Week, supported by The Carter Center and ITI, took place in May 2016. Approximately 7.4 million people across 70 districts received Zithromax®. (All photos courtesy of The Carter Center.)

May 10, 2016

World Health Organization (WHO) brings together ministry of health representatives, NGO partners, donors and academics for annual GET 2020 meeting.

November 16, 2015

- Trachoma is the Leading Infectious Cause of Blindness -

- More Than 100 Government, Non-Governmental and Private Sector Partners Driving Progress -

- Continued Efforts Needed to Reach 2020 Global Elimination Goal

ADDIS ABABA, ETHIOPIA--The International Trachoma Initiative (ITI), Pfizer Inc. and International Coalition for Trachoma Control (ICTC) partners announce Pfizer’s donation of the 500 millionth dose of Zithromax® (azithromycin) Tablets, an antibiotic used to treat trachoma in certain countries. The milestone marks significant achievement in global efforts to help eliminate this infectious and preventable eye disease that can lead to permanent blindness as a public health threat by the year 2020.

Today, delegations from the U.K. and U.S. governments, non-governmental organizations (NGOs) and Pfizer are gathering in the Wolisso region of Ethiopia to celebrate the donation of the 500 millionth Zithromax dose and a significant expansion of the national trachoma elimination program in the country.

November 14, 2014

The following is a press release from the Queen Elizabeth Diamond Jubliee Trust dated November 14, 2014.

14 November 2014, Maputo, Mozambique: Today the Mozambican government is launching an historic five-year Initiative to make significant advances towards the elimination of blinding trachoma across the country, with the support of The Queen Elizabeth Diamond Jubilee Trust (the Trust).  The Queen Elizabeth Diamond Jubilee Trust Trachoma Initiative (the Initiative), spearheaded by the Mozambique Ministry of Health, aims to treat and protect people suffering from this painful eye disease across endemic regions.

October 03, 2014

The Kenyan government has launched an historic five-year initiative to eliminate blinding trachoma across the country by early 2019, with the support of The Queen Elizabeth Diamond Jubilee Trust (the Trust).  The Queen Elizabeth Diamond Jubilee Trust Trachoma Initiative, spearheaded by the Kenyan Ministry of Health, aims to consign this debilitating disease to history across the entire country.

To achieve this ambitious goal, the Kenyan government will be working with members of the International Coalition for Trachoma Control (ICTC), coordinated by Sightsavers, an international charity focused on the elimination of avoidable blindness. The initiative was launched in Kenya on Oct. 1.

April 23, 2014
Photos courtesy of Dominic Nahr/Magnum/Sightsavers.
 
Largest infectious disease mapping project ever attempted celebrates two year milestone
 

The Global Trachoma Mapping Project (GTMP), funded by the UK government, is using mobile technology to support the elimination of the blinding disease trachoma by mapping its global prevalence.  As the project reaches its second anniversary its initial scope of work has nearly been completed, with 94 per cent of the identified districts surveyed nine months ahead of schedule and under budget.

January 01, 2014

Paul Emerson recently returned from the Amhara region of Ethiopia, where the 100 millionth dose of donated Zithromax was distributed by The Carter Center. Photo by William Vazquez for Pfizer

ATLANTA – Dr. Paul Emerson will join The Task Force for Global Health as director of the International Trachoma Initiative (ITI). His appointment begins January 6, 2014.  As director, Dr. Emerson will be responsible for the overall success of ITI’s trachoma elimination efforts with program partner Pfizer to achieve the global elimination of blinding trachoma by 2020. Dr. Emerson joins ITI from The Carter Center where he has been director of the Trachoma Control Program since 2004.  Through ITI, Pfizer has distributed 340 million treatments of donated Zithromax® to treat and prevent blinding trachoma in 28 countries in Africa and Asia.  The Carter Center recently distributed the 100 millionth dose of Zithromax® donated by Pfizer in Ethiopia.